• SENSEX 81,911.01
    31.61 (+0.04%)
  • BANKNIFTY 61,518.50
    726.10 (+1.19%)
  • NSE
    1,994.50 1,994.50(%)
  • Reliance Industries
    1,342.10 1,611.20(%)
  • ICICI Bank
    1,592.20 1,616.70(%)
  • Kalyan Jewellers
    716.00 716.00(%)
  • Cupid
    389.00 389.00(%)
  • HDFC Bank
    813.90 1,017.90(%)
  • Sai Life
    1,881.05 786.15(%)
  • SBI
    1,089.00 1,234.80(%)
  • Kotak Mah. Bank
    494.00 494.00(%)
  • Page Industries
    31,752.10 29,800.00(%)
  • M & M
    3,369.00 2,743.15(%)
  • Gabriel India
    1,690.25 1,690.25(%)
  • Bharti Airtel
    2,071.35 1,726.05(%)
  • Cummins India
    4,311.70 6,142.80(%)
  • N S D L
    815.00 1,180.00(%)
  • Hind.Aeronautics
    4,738.80 3,479.20(%)
  • Avanti Feeds
    798.20 1,592.30(%)
  • Indegene
    672.00 672.00(%)
  • Lenskart Solut.
    738.30 767.40(%)
  • Hindustan Copper
    467.35 759.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kerala Ayurveda Ltd Pharmaceuticals - Indian - Formulations

  • MNC Associate
  • BSE Code : 4855.0
  • ISIN : INE817B01025
152.10 -16 (-9.38%)
  • As on 12 Nov 2026 (EOD)

  • Today’s Low

    151.10

  • Today’s High

    173.80

  • Open

    173.80

  • Perv Close

    167.85

  • 52W Low

    130.00

  • 52W High

    404.95

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    207.62

  • Div & Yield %

    0.00

  • Book Value(₹)

    35.84

  • Debt-Equity Ratio

    -9.38

  • AGM Date

    12-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    6.13

  • Mar.Cap (₹Cr.)

    207.62

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    13.65

  • BV (₹)

    35.80

  • Sales( ₹ in Cr.)

    85.48

  • NP (in Cr.)

    -14.74

  • NP Var(%)

    -7.0

  • Div%

    0.0

  • CPS (₹)

    -8.20

  • EPS (₹)

    -10.80

  • Traded Value (₹ in Lakhs)

    207.62

  • 52 Week High

    404.95

  • 52 Week Low

    130.00

  • Price BSE

    152.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    207.62

  • P/C Ratio

    -18.60

  • P/E Ratio

    -14.10

  • Price Vs.BV

    -10.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 77.95 73.14 63.30 55.80 43.20 53.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 77.95 73.14 63.30 55.80 43.20 53.68
Other Income 5.17 3.01 0.06 0.30 0.17 0.16
Stock Adjustments 0.29 3.32 -0.11 0.27 -1.65 0.36
Total Income 83.41 79.47 63.25 56.37 41.72 54.20
EXPENDITURE :            
Raw Materials 21.53 23.00 17.55 16.37 12.92 13.98
Power and Fuel Cost 1.71 2.12 2.08 2.01 1.09 1.72
Employee Cost 35.52 20.23 15.98 12.17 13.06 16.03
Other Manufacturing Expenses 2.77 3.86 4.06 3.26 3.13 4.52
Selling and Administration Expenses 26.76 21.98 18.21 14.02 11.13 14.50
Miscellaneous Expenses 2.55 1.47 -2.47 0.52 0.01 0.20
Employee Benefit Expenses 35.52 20.23 15.98 12.17 13.06 16.03
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 90.83 72.66 55.42 48.34 41.34 50.94
Operating Profit -7.41 6.81 7.82 8.03 0.38 3.26
Interest 3.92 5.40 4.81 6.03 6.14 1.37
Gross Profit -11.33 1.41 3.01 2.00 -5.76 1.89
Depreciation 2.15 1.57 0.64 0.77 0.82 0.68
Profit Before Tax -13.48 -0.16 2.37 1.23 -6.58 1.21
Current Tax 0.28 0.06 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.02 -0.28 -0.52 0.35 -1.63 0.34
Reported Net Profit -13.78 0.05 2.89 0.89 -4.95 0.88
Extraordinary Items 0.00 0.00 2.43 0.00 0.00 0.00
Adjusted Net Profit -13.78 0.05 0.46 0.89 -4.95 0.88
Adjustment below Net Profit -9.70 -9.96 0.37 0.34 0.32 0.30
P & L Balance brought forward -8.41 -8.11 -11.37 -12.60 -7.97 -9.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -31.89 -18.02 -8.11 -11.37 -12.60 -7.97
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -11.45 0.04 2.74 0.84 -4.69 0.83
Earnings Per Share(Adj)-Unit Curr -11.45 0.04 2.74 0.84 -4.69 0.83
Book Value 20.88 27.24 13.77 10.68 9.51 13.90
Book Value(Adj)-Unit Curr 20.88 27.24 13.77 10.68 9.51 13.90

Shareholding Pattern

  • Promoter Group

    38.70%

  • Public Share Holding

    61.30%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 3,996,627 29.28 3,996,627 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,996,627 29.28 3,996,627 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,285,399 9.42 1,285,399 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,285,399 9.42 1,285,399 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,709 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 20,000 0.15 20,000 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,976 0.02 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 24,685 0.18 20,000 3
2] Non Institution
Bodies Corporate 1,510,123 11.06 1,501,137 103
Clearing Members 0 0.00 0 0
Directors of their Relatives 473,899 3.47 473,899 5
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 227,484 1.67 85,922 176
Foreign Non Institution Other 25,737 0.19 0 1
Hindu Undivided Families 609,003 4.46 609,003 183
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,904,278 21.28 2,904,278 38
Individuals holding nominal share capital up to Rs. 1 lakh 2,557,166 18.73 2,417,337 10,053
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,111 0.02 1,991 6
Sub Total 8,343,374 61.12 8,027,140 10,574
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,650,085 100.00 13,329,166 10,580

Company Background

Kerala Ayurveda LtdPharmaceuticals - Indian - Formulations

  • Kerala Ayurveda Ltd
  • BSE Code : 4855.0
  • ISIN : INE817B01025

  • Incorporation Year

    1992

  • Registered Office

    VII/415 Nedumbassery
    Athani P O Aluva, Ernakulam,
    Kerala-683585

  • Telephone

    91-484-2476301/2/3/4

  • FAX

    91-484-2474376

  • Chairman

    Ramesh Vangal

  • Managing Director

  • Company Secretary

  • Auditor

    G Joseph & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Integrated Registry Mgt Servic
    Kences Tower ,
    2nd Floor No 1 ,Ramakrishna Street
    Mumbai - Chennai - 600 017

Kerala Ayurveda Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kerala Ayurveda 152.10 77.86 72.69 -8.48 0.00
Abbott India 26,603.60 7,217.19 6,929.05 34.20 43.78
Astrazeneca Phar 6,431.20 2,304.07 2,275.58 90.47 27.86
Glaxosmi. Pharma 2,655.30 3,932.76 3,790.20 39.45 58.17
Evonile Pharma 1,583.60 393.10 354.33 -1,389.12 15.94
Cipla 1,410.00 20,102.60 18,979.95 42.97 13.88
Bliss GVS Pharma 641.15 773.53 729.81 41.80 12.51
Amrutanjan Healt 507.50 520.13 502.55 25.61 24.16
Fermenta Biotec. 472.10 474.15 450.25 22.31 18.77
Guj. Themis Bio. 388.05 168.25 165.82 103.76 18.05
Ambalal Sarabhai 36.76 19.52 3.94 62.31 6.77